Scancell
Lindy is an internationally recognized immunologist in the field of tumor therapy and co-founder of Scancell. She has worked for over 25 years in translational research, developing products for clinical trials including monoclonal antibodies and cancer vaccines. She has a personal Chair in Cancer Immunotherapy in the Department of Clinical Oncology at the University of Nottingham.
This person is not in any offices
Scancell
Scancell's mission is to overcome this breach in defenses by developing products that stimulate the immune system to treat or prevent cancer.